Warren Buffett Just Sold $4 Billion of Apple Stock. He Used $1.5 Billion of the Money to Buy This Beaten-Down Stock.

Berkshire Hathaway, led by Warren Buffett, divested approximately $4 billion in Apple stock during Q2 2025, while concurrently deploying around $1.5 billion into UnitedHealth Group. This significant portfolio reallocation, involving the sale of 20 million Apple shares and the acquisition of 5.04 million UnitedHealth shares, reflects a strategic shift towards a healthcare insurer. The move aligns with Buffett's value-oriented approach and historical comfort with the insurance sector, suggesting a preference for perceived stability and attractive valuation in UnitedHealth over Apple's current risk profile.

Analysis

Berkshire Hathaway's Q2 2025 13-F filing reveals a significant portfolio rotation, marked by a divestment of approximately $4 billion in Apple (AAPL) stock and a new $1.57 billion investment in UnitedHealth Group (UNH). The sale of 20 million Apple shares, reducing Berkshire's stake by 6.7%, continues a multi-quarter trend of trimming the position, despite recent public praise for Apple's management. This move is juxtaposed against Apple's relatively high valuation, cited at a 35.8 P/E ratio, and potential risks surrounding new product adoption and M&A strategy. Conversely, the acquisition of 5.04 million UNH shares at an estimated average cost near $312 per share represents a classic value-oriented play. The investment thesis for UNH is anchored in its depressed valuation, with a price-to-earnings ratio at a multi-year low, and the assessment that its primary headwind—unexpectedly high medical costs in Medicare Advantage plans—is a temporary issue likely to be resolved by premium increases next year. While an ongoing Department of Justice investigation presents a risk, the analysis suggests UNH has a history of navigating such probes effectively. This strategic shift from a high-multiple technology leader to a beaten-down healthcare giant indicates a tactical preference for near-term value and perceived lower risk.

Key Decisions for Investors

• Investors should consider this as a signal to re-evaluate exposure to high-multiple technology stocks like AAPL versus undervalued blue-chips, mirroring Berkshire's rotation towards perceived near-term value.
• For those considering UnitedHealth Group, the investment case is contingent on the company's ability to successfully raise premiums in the coming year to offset higher medical costs; therefore, monitoring updates on Medicare Advantage pricing is critical.
• Holders of Apple should note that a sophisticated, long-term investor is systematically trimming a large position, which warrants a reassessment of the stock's risk/reward profile at its current valuation, especially in light of execution risks with new products and potential acquisitions.